Vident Investment Advisory, LLC Argenx Se Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $19,051 - $23,008	-57 Reduced 2.59%	2,140 $797,000
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $80,409 - $94,542	235 Added 11.98%	2,197 $832,000
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $38,095 - $43,928	-111 Reduced 5.35%	1,962 $642,000
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $487,670 - $685,393	-1,809 Reduced 46.6%	2,073 $784,000
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $162,084 - $223,625	637 Added 19.63%	3,882 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $400,670 - $520,013	-1,473 Reduced 31.22%	3,245 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$295.0 - $350.58 $99,710 - $118,496	-338 Reduced 6.69%	4,718 $1.43 Million
Q2 2021 Aug 13, 2021	SELL	$257.11 - $319.92 $179,462 - $223,304	-698 Reduced 12.13%	5,056 $1.52 Million
Q4 2020 Feb 08, 2021	BUY	$248.13 - $308.36 $26,549 - $32,994	107 Added 1.89%	5,754 $1.69 Million
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $81,031 - $102,463	-376 Reduced 6.24%	5,647 $1.48 Million
Q2 2020 Jul 17, 2020	SELL	$127.44 - $232.72 $420,552 - $767,976	-3,300 Reduced 35.4%	6,023 $1.36 Million
Q1 2020 May 12, 2020	SELL	$108.83 - $165.23 $70,848 - $107,564	-651 Reduced 6.53%	9,323 $1.23 Million
Q4 2019 Feb 11, 2020	SELL	$106.59 - $164.21 $133,344 - $205,426	-1,251 Reduced 11.14%	9,974 $1.6 Million
Q3 2019 Nov 13, 2019	SELL	$113.31 - $150.51 $36,372 - $48,313	-321 Reduced 2.78%	11,225 $1.28 Million
Q2 2019 Aug 12, 2019	SELL	$115.0 - $141.58 $392,610 - $483,354	-3,414 Reduced 22.82%	11,546 $1.64 Million
Q1 2019 May 08, 2019	SELL	$98.85 - $134.59 $38,946 - $53,028	-394 Reduced 2.57%	14,960 $1.87 Million
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $979,738 - $1.69 Million	15,354 New	15,354 $1.48 Million
Q2 2018 Aug 14, 2018	SELL	$74.84 - $100.16 $517,368 - $692,406	-6,913 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$56.95 - $85.19 $393,695 - $588,918	6,913 New	6,913 $593,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.66 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$778 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account